4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-23-006325
Chief Commercial Ofc Imm Med sold 11,749 shares at $8.57 ($100,689)
- Chief Commercial Ofc Imm Med acquired 132,979 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Commercial Ofc Imm Med | 2023-03-06 | Grant or award | +132,979 | 235,575 | D | ||
| BENZENO SHARON Chief Commercial Ofc Imm Med | 2023-03-06 | Sale | −11,749 | $8.57 | $100,689 | 223,826 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Commercial Ofc Imm Med | 2023-03-06 | Grant or award · Stock Option (right to buy) | +199,549 | 199,549 | D | ||
| Open-market sales · 11,749 sh · avg $8.57 · $100,689 | |||||||
Loading xslF345X03/form4.xml…